{"id":"https://openalex.org/W2249055167","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.7637","title":"Tumor response and progression-free survival (PFS) as potential surrogate endpoints for overall survival (OS) in extensive-stage small cell lung cancer (ES-SCLC): Findings based on North Central Cancer Treatment Group (NCCTG) trials.","display_name":"Tumor response and progression-free survival (PFS) as potential surrogate endpoints for overall survival (OS) in extensive-stage small cell lung cancer (ES-SCLC): Findings based on North Central Cancer Treatment Group (NCCTG) trials.","publication_year":2010,"publication_date":"2010-05-20","ids":{"openalex":"https://openalex.org/W2249055167","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.7637","mag":"2249055167"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2010.28.15_suppl.7637","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.7637","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.7637","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008026182","display_name":"Nathan R. Foster","orcid":"https://orcid.org/0000-0002-2874-1295","observed_orcids":["https://orcid.org/0000-0002-2874-1295"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N. R. Foster","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051835996","display_name":"Yueli Qi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y. Qi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Q. Shi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Q. Shi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109999660","display_name":"James Edward Krook","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. E. Krook","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113153502","display_name":"J. W. Kugler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. W. Kugler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110029856","display_name":"J. R. Jett","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. R. Jett","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038755935","display_name":"Julian R. Molina","orcid":"https://orcid.org/0000-0002-9962-4635","observed_orcids":["https://orcid.org/0000-0002-9962-4635"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. R. Molina","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062848479","display_name":"Steven E. Schild","orcid":"https://orcid.org/0000-0002-2850-4126","observed_orcids":["https://orcid.org/0000-0002-2850-4126"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. E. Schild","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113962365","display_name":"Alex A. Adjei","orcid":"https://orcid.org/0000-0002-8039-6556","observed_orcids":["https://orcid.org/0000-0002-8039-6556"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. A. Adjei","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5047322962","display_name":"S. J. Mandrekar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. J. Mandrekar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"28","issue":"15_suppl","first_page":"7637","last_page":"7637"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.007400000002235174,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/extensive-stage-small-cell-lung-cancer","display_name":"extensive-stage small cell lung cancer","score":0.9210000038146973},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9589999914169312},{"id":"https://openalex.org/keywords/surrogate-endpoints","display_name":"surrogate endpoints","score":0.953000009059906},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9850000143051147},{"id":"https://openalex.org/keywords/best-response","display_name":"best response","score":0.7210000157356262},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.8330000042915344},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9459999799728394},{"id":"https://openalex.org/keywords/individual-patient-data-meta-analysis","display_name":"individual patient data meta-analysis","score":0.6940000057220459},{"id":"https://openalex.org/keywords/landmark-analysis","display_name":"landmark analysis","score":0.6769999861717224},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.625},{"id":"https://openalex.org/keywords/treatment-heterogeneity","display_name":"treatment effect heterogeneity","score":0.3310000002384186},{"id":"https://openalex.org/keywords/treatment-effect-generalizability","display_name":"treatment effect generalizability","score":0.3580000102519989}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8564841747283936},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6841626167297363},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6099564433097839},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.5848705172538757},{"id":"https://openalex.org/C141341695","wikidata":"https://www.wikidata.org/wiki/Q2368661","display_name":"Surrogate endpoint","level":2,"score":0.5620332956314087},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5298654437065125},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.5128698348999023},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5075188875198364},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4422071576118469},{"id":"https://openalex.org/C160798450","wikidata":"https://www.wikidata.org/wiki/Q4230870","display_name":"Concordance","level":2,"score":0.44061028957366943},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43795400857925415},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.41993483901023865},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4104287922382355},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.37192070484161377},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.3328374922275543},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2010.28.15_suppl.7637","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.7637","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.7637","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1521811891","https://openalex.org/W998056773","https://openalex.org/W851077011","https://openalex.org/W1586214353","https://openalex.org/W2225290712","https://openalex.org/W4415197070","https://openalex.org/W4414615777","https://openalex.org/W4210423162","https://openalex.org/W7162693596","https://openalex.org/W2047371689"],"abstract_inverted_index":{"7637":[0],"Background:":[1],"We":[2],"investigated":[3],"the":[4,64,90,101,104,164,205,219,224,246],"putative":[5],"surrogate":[6,25,287],"endpoints":[7,26],"(PSEs)":[8],"of":[9,96,103,187,227,245,277,300,315],"best":[10],"response":[11,14],"(BR),":[12],"confirmed":[13],"(CoR),":[15],"and":[16,22,44,66,80,109,120,143,156,160,166,171,250,290],"PFS":[17,157,178,203,222,242,259,266,280,329],"for":[18,27,34,229,288,317],"association":[19,102],"with":[20,201,263],"OS,":[21,264,289],"as":[23,268,270,284],"possible":[24],"OS.":[28],"Methods:":[29],"Individual":[30],"patient":[31],"(pt)":[32],"data":[33,295],"870":[35],"untreated":[36],"ES-SCLC":[37],"pts":[38,49],"from":[39,50,129,145,296],"6":[40,81],"single-arm":[41],"(274":[42],"pts)":[43],"3":[45],"randomized":[46,301],"trials":[47],"(596":[48],"32":[51],"participating":[52],"centers)":[53],"containing":[54],"platinum":[55],"or":[56],"paclitaxel-based":[57],"regimens":[58],"were":[59,68,114,158,169],"pooled.":[60],"Patient-level":[61,174],"associations":[62,175],"between":[63],"PSEs":[65,97],"OS":[67,108,155,230,249],"assessed":[69,99],"by":[70,100],"Cox":[71],"models":[72],"using":[73,89,294],"a":[74,130,146,184,252,274,285,297],"landmark":[75],"analyses":[76],"at":[77,180],"2,":[78],"4,":[79],"months":[82,182,272],"post-study":[83],"entry.":[84],"Model":[85],"discrimination":[86],"was":[87,98,183,260,273],"evaluated":[88],"concordance":[91],"(c)":[92],"index.":[93],"Trial-level":[94,124,320],"surrogacy":[95,125,228,254,321],"treatment":[105],"effects":[106,113],"on":[107],"individual":[110],"PSEs.":[111],"Treatment":[112],"estimated":[115],"through":[116],"log":[117,121],"hazard":[118],"ratios":[119],"odds":[122],"ratios.":[123],"measures":[126,322],"included:":[127],"R2":[128,144,235,324,326],"weighted":[131],"least":[132],"squares":[133],"regression":[134],"model":[135,149],"(R2":[136,150,231],"WLS),":[137],"Spearman":[138,328],"rank":[139],"correlation":[140],"coefficient":[141],"(Spearman),":[142],"bivariate":[147],"survival":[148,189],"Copula).":[151],"Results:":[152],"The":[153],"median":[154],"9.6":[159],"5.5":[161],"months,":[162],"respectively;":[163],"BR":[165,337],"CoR":[167,341],"rates":[168],"44%":[170],"34%,":[172],"respectively.":[173],"showed":[176,223],"that":[177,241],"status":[179,267],"4":[181,271],"strong":[185,275],"predictor":[186,276],"subsequent":[188,278],"(HR=0.42":[190],"[95%":[191,208],"CI:":[192,209,333],"0.35,":[193,210],"0.51];":[194],"c-index":[195,212],"=":[196,213,233,237],"0.63;":[197],"p":[198,215],"<":[199,216],"0.01),":[200],"6-month":[202],"being":[204],"strongest":[206],"(HR=0.41":[207],"0.49];":[211],"0.66;":[214],"0.01).":[217],"At":[218],"trial":[220],"level,":[221],"highest":[225],"level":[226],"WLS":[232,325],"0.79;":[234],"Copula":[236,327],"0.80),":[238],"which":[239],"indicates":[240],"explained":[243],"79%":[244],"variance":[247],"in":[248],"is":[251],"good":[253],"measure":[255],"(see":[256],"Table).":[257],"Conclusions:":[258],"strongly":[261],"associated":[262],"where":[265],"early":[269],"survival.":[279],"also":[281],"shows":[282],"promise":[283],"potential":[286],"needs":[291],"further":[292],"validation":[293],"larger":[298],"number":[299],"phase":[302],"III":[303],"trials.":[304],"This":[305],"data,":[306],"if":[307],"substantiated,":[308],"will":[309],"allow":[310],"faster":[311],"yet":[312],"valid":[313],"evaluation":[314],"drugs":[316],"ES-":[318],"SCLC.":[319],"Endpoint":[323],"0.79":[330],"0.80":[331],"(95%":[332],"0.67,":[334],"0.93)":[335],"0.75":[336],"0.21":[338],"NA":[339,343],"0.52":[340],"0.40":[342],"0.60":[344],"No":[345],"significant":[346],"financial":[347],"relationships":[348],"to":[349],"disclose.":[350]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}